STAAR Surgical, based in Monrovia, United States, develops and manufactures high-quality visual implants and lenses aimed at improving patients' vision. The company specializes in implantable contact lenses (ICLs) for treating refractive disorders such as myopia and also produces products for cataract and glaucoma surgeries. STAAR Surgical's mission is to provide innovative solutions that enhance visual freedom and improve the quality of life for patients worldwide.
STAAR Surgical has achieved significant milestones, including the sale of over one million lenses globally. The company's EVO ICL™ has received high patient satisfaction, with a substantial percentage willing to undergo the procedure again. STAAR Surgical has also secured strategic agreements, such as the one with IQ Laser Vision, and participates in major industry conferences like the Goldman Sachs Annual Global Healthcare Conference. These achievements underscore its impact and leadership in the ophthalmic medical device market.
